:::

詳目顯示

回上一頁
題名:近期美國多方複審(IPR)制度修正對製藥產業影響
書刊名:智慧財產權月刊
作者:李秉燊陳豐奇
作者(外文):Lee, Pin-shenChen, Feng-chi
出版日期:2020
卷期:255
頁次:頁32-48
主題關鍵詞:多方複審專利審判暨上訴委員會製藥產業判決先例意見小組申請專利範圍解釋專利更正動議Inter partes reviewPatent trial and appeal boardPharmaceutical industryPrecedential opinion panelClaim constructionMotion to amend
原始連結:連回原系統網址new window
相關次數:
  • 被引用次數被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
  • 排除自我引用排除自我引用:0
  • 共同引用共同引用:22
  • 點閱點閱:2
期刊論文
1.朱浩筠(20160900)。美國專利舉發制度及其相關爭議問題簡介以多方複審(IPR)案件為中心。智慧財產權月刊,213,5-25。new window  延伸查詢new window
2.顏吉承(20150100)。申請專利範圍的最寬廣合理解釋及客觀合理解釋。專利師,20,1-17。new window  延伸查詢new window
3.楊智傑、黃婷翊(20161000)。美國專利複審程序及Cuozzo Speed Technologies, LLC v. Lee案。專利師,27,18-57。new window  延伸查詢new window
4.張哲倫(20150400)。專利連結之歷史、緣由及其政策功能。智慧財產權月刊,196,5-19。new window  延伸查詢new window
5.張仁平(20170700)。我國專利法有關「解釋申請專利範圍」之條文的探討。專利師,30,94-128。new window  延伸查詢new window
6.陳在方(20171200)。美國專利紛爭解決之關鍵性變革--論美國專利複審程序的結構功能分析與實施成效。交大法學評論,2,1-62。new window  延伸查詢new window
7.Dolin, Gregory(2015)。Dubious Patent Reform。Boston College Law Review,56(3),881-948。  new window
8.Consilvio, Mark、Stroud, Jonathan R. K.(2013)。Unraveling the USPTO's Tangled Web: An Empirical Analysis of the Complex World of Post-Issuance Patent Proceedings。J. INTELL. PROP. L.,21。  new window
9.Love, Brian J.、Miller, Shawn P.、Ambwani, Shawn(2019)。Determinants of Patent Quality: Evidence from Inter Partes Review Proceedings。U. COLO. L. Rev.,90。  new window
10.朱淑尹(20150400)。美國專利連結制度中專利登錄的介紹與探討。智慧財產權月刊,196,20-33。new window  延伸查詢new window
11.王世仁(20190300)。美國專利多方複審制度與相關法院判決。智慧財產權月刊,243,51-66。new window  延伸查詢new window
12.Xu, Nora(2017)。AIA Proceedings: A Prescription for Accelerating the Availability of Generic Drugs。Emory Law Journal,66(4),1007-1066。  new window
13.Wasserman, Melissa F.(2013)。The Changing Guard of Patent Law: Chevron Deference for the PTO。William and Mary Law Review,54(6),1959-2019。  new window
14.Sturiale, Jennifer E.(2017)。Hatch-Waxman Patent Litigation and Interpartesreview: A New Sort of Competition。Alabama Law Review,69。  new window
15.陳秉訓(20091100)。美國專利訴訟制度:以專利有效性問題為中心。智慧財產權月刊,131,67-101。new window  延伸查詢new window
16.蘇昱婷、劉尚志(20130900)。臺灣企業於美國國際貿易委員會專利訴訟之實證研究。智慧財產權月刊,177,56-104。new window  延伸查詢new window
研究報告
1.蔣大中(2014)。美國專利制度與橘皮書登錄制度研究。  延伸查詢new window
圖書
1.廖瑋婷(2018)。專利舞蹈怎麼跳?美國生物相似藥上市與訴訟。  延伸查詢new window
其他
1.Quinn, Gene(20180617)。Why should we encourage generics to challenge pharma patents?,http://www.ipwatchdog.com/2018/06/17/why-encourage-generics-challenge-pharma-patents/id=98493/。  new window
2.李秉燊(20180712)。再掀波瀾:美國參議員提案禁止學名藥廠於專利連結訴訟外提起專利複審,http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Industry_Economy/IPNC_180711_0703.htm?fbclid=IwAR2qwcLqIWyTodp5l4ETNlQgAo5L8vxlro6-wnZaGkWCDCOFSF3c15TW36Y。  延伸查詢new window
3.(2019)。專利商標審查及爭議業務修法芻議,https://www.tipo.gov.tw/public/Attachment/92201203648.pdf。  延伸查詢new window
4.Barry, Chris(2014)。2014 Patent Litigation Study: As Case Volume Leaps, Damages Continue General Decline 16,http://www.pwc.com/en_US/us/forensic-services/publications/assets/2014-patent-litigation-study.pdf。  new window
5.Divine, David A.。2013 Report of The Economic Survey,American Intellectual Property Law Ass'n。,http://www.patentinsurance.com/custdocs/2013aipla%20survey.pdf。  new window
6.朱子亮(20160126)。美國聯邦最高法院同意審理:IPR適用最寬廣合理解釋原則(In re Cuozzo Speed),http://iknow.stpi.narl.org.tw/post/Read.aspx?PostID=12097。  延伸查詢new window
7.朱子亮(20170425)。專利有效性判決一致性:美CAFC法院說明USPTO專利複審結果無需與聯邦法院有一致性(Novartis AG v. Noven Pharmaceuticals),http://iknow.stpi.narl.org.tw/Post/Read.aspx?PostID=13362。  延伸查詢new window
8.楊智傑(20190123)。專利審理暨救濟委員會準司法化審理是否違憲?2018年美國最高法院Oil States Energy Services v. Greene's Energy Group案,http://www.naipo.com/Portals/1/web_tw/Knowledge_Center/Infringement_Case/IPNC_190123_0502.htm。  延伸查詢new window
9.PTAB(2018)。Trial Practice Guide August 2018 Update,https://www.uspto.gov/sites/default/files/documents/2018_Revised_Trial_Practice_Guide.pdf。  new window
10.SOP 2(rev. 10): Precedential opinion panel to decide issues of exceptional importance involving policy or procedure,https://www.uspto.gov/sites/default/files/documents/SOP2%20R10%20FINAL.pdf。  new window
11.Bultman, Matthew(20190319)。Patent Amendments Face Better Odds Under New AIA Plan,https://www.law360.com/articles/1140532。  new window
12.Rapalino, Emily L.,Delsignore, Marta E.,Naik, Khurram(20190326)。USPTO Creates Pilot Program For New Motion To Amend Practice,https://www.goodwinlaw.com/publications/2019/03/03_26_19-uspto-creates-pilotprogram。  new window
13.Patent Trial and Appeal Board Motion to Amend Study,https://www.uspto.gov/sites/default/files/documents/ptab_%20mta_study_%28installment_5_-_%20update_through_fy2018%29.pdf。  new window
14.Ruschke, David P.(20171121)。Guidance on Motions to Amend in view of Aqua Products, Memorandum,https://www.uspto.gov/sites/default/files/documents/guidance_on_motions_to_amend_11_2017.pdf。  new window
15.McCorquindale, J. Derek,Ward, Trenton A.。The USPTO Creates a Sweeping New Pilot Program for Motions to Amend,https://www.finnegan.com/en/insights/blogs/america-invents-act/the-uspto-creates-a-sweeping-new-pilot-program-for-motions-toamend.html。  new window
16.Krieger, Justin(20190321)。Promising Signs For Patent Owners Amending At PTAB,https://www.law360.com/articles/1141409。  new window
17.Duncan, Kelly,Kokoll, Emily(20181022)。4 Recent PTAB Decisions Attys Need To Know,https://www.law360.com/articles/1094149。  new window
 
 
 
 
第一頁 上一頁 下一頁 最後一頁 top
:::
無相關博士論文
 
無相關書籍
 
無相關著作
 
QR Code
QRCODE